Stem Cell Research & Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

23小时前 ms5000001675876209 来自广东省

想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2024-04-22 ms7000000968424240 来自江苏省

偏重的研究方向：干细胞;间充质干细胞;干细胞治疗
经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。

31 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2021-05-10 krygios

偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration
经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒

129 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2023-07-09 Zhudingding 来自北京

2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。

73 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2024-01-02 加油！来自江苏省

偏重的研究方向：干细胞
经验分享：记录一下，怂怂怂
Submitted to Journal: 12 Dec 2023
Editor Assigned: 13 Dec 2023
Under Review: 25 Dec 2023
Reviews Completed: 31 Dec 2023

39 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2024-02-09 ms4000002111139793 来自山西省

偏重的研究方向：干细胞;干细胞治疗
经验分享：想知道投的这个杂志的综述容易接收吗

45 0

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2023-06-14 ms8000000826346257 来自山西省

投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录...

83 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2023-11-15 starter2009 来自北京

投稿当天Editor Assigned，已经半个月了

52 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2023-03-27 Faith Mary 来自四川省

二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？

60 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=23小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2168737, encodeId=27182168e3763, content=投稿当天Editor Assigned，已经半个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Nov 15 23:42:38 CST 2023, time=2023-11-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122044, encodeId=65b1212204407, content=二修回来with editor一个多月了，发邮件说在排队最后的审查，喊耐心等待，一般多久能有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ODeKY4DVIELYC1ytUiaBuFnrx3vOYFTSZMUGGIk5n4Gatk2rxXia7gicAt397bBdKPJyvITxE9tW0TwMibw8hppCsQ/132, createdBy=86a32307035, createdName=Faith Mary, createdTime=Mon Mar 27 12:18:18 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2142949, encodeId=6ea82142949f3, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：慎重投稿！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c07d8565212, createdName=ms2000000073569811, createdTime=Thu Jun 15 14:32:08 CST 2023, time=2023-06-15, status=1, ipAttribution=上海)]

2023-06-15 ms2000000073569811 来自上海

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：干细胞
经验分享：慎重投稿！！！！！！！

77 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务